Diverse clonal fates emerge upon drug treatment of homogeneous cancer cells Y Goyal, GT Busch, M Pillai, J Li, RH Boe, EI Grody, M Chelvanambi, ... Nature 620 (7974), 651-659, 2023 | 58 | 2023 |
Systems-level network modeling deciphers the master regulators of phenotypic plasticity and heterogeneity in melanoma M Pillai, MK Jolly IScience 24 (10), 2021 | 24 | 2021 |
Unraveling non-genetic heterogeneity in cancer with dynamical models and computational tools M Pillai, E Hojel, MK Jolly, Y Goyal Nature Computational Science 3 (4), 301-313, 2023 | 16 | 2023 |
Quantitative landscapes reveal trajectories of cell-state transitions associated with drug resistance in melanoma M Pillai, Z Chen, MK Jolly, C Li IScience 25 (12), 2022 | 14 | 2022 |
Mapping phenotypic heterogeneity in melanoma onto the epithelial-hybrid-mesenchymal axis M Pillai, G Rajaram, P Thakur, N Agarwal, S Muralidharan, A Ray, ... Frontiers in Oncology 12, 913803, 2022 | 10 | 2022 |
Systematic evolution of initiation factor 3 and the ribosomal protein uS12 optimizes Escherichia coli growth with an unconventional initiator tRNA M Datta, J Singh, MJ Modak, M Pillai, U Varshney Molecular Microbiology 117 (2), 462-479, 2022 | 7 | 2022 |
A mutation in the ribosomal protein uS12 reveals novel functions of its universally conserved PNSA loop M Datta, M Pillai, MJ Modak, A Liiv, FT Khaja, T Hussain, J Remme, ... Molecular Microbiology 115 (6), 1292-1308, 2021 | 7 | 2021 |
Emergent dynamics of underlying regulatory network links EMT and androgen receptor-dependent resistance in prostate cancer R Jindal, A Nanda, M Pillai, KE Ware, D Singh, M Sehgal, AJ Armstrong, ... Computational and structural biotechnology journal 21, 1498-1509, 2023 | 4 | 2023 |
Dynamical hallmarks of cancer: phenotypic switching in melanoma and epithelial-mesenchymal plasticity P Jain, M Pillai, AS Duddu, JA Somarelli, Y Goyal, MK Jolly Seminars in Cancer Biology, 2023 | 2 | 2023 |